Ladenburg Thalmann & Co. Inc. acted as exclusive placement agent for the offerings.
Calidi Biotherapeutics, Inc. (NYSE AMERICAN: CLDI) (“Calidi” or the “Company”), a clinical-stage biotechnology company developing a new generation of targeted immunotherapies, today announced that it ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback